The present invention relates to compounds of Formula I for use in inhibiting cell migration. Further, the invention relates to a compound of Formula I for use in preventing and/or treating restenosis, for use in treating cancer and for use in preventing and/or treating cardiovascular diseases. Likewise, the invention relates to the use of a compound of Formula I for inhibiting cellular migration and/or the turnover of focal adhesions in vitro.
